Now that they have the funding, there is just no reasonable excuse not to take up the POS option. Start buying any equipment required to modify or upgrade the POS plant and start removing the overburden in parallel. We should be producing Spodumene as soon as possible as originally intended. We're now not dependent on any offtakers for funding so can sell to the highest (Chinese) bidders on the spot market.